摘要
目的:探讨减低剂量TA化疗方案对于高龄急性髓系白血病的治疗效果。方法:收治高龄急性髓系白血病患者42例,随机分为对照组和观察组,各21例。对照组给予标准剂量TA方案化疗,观察组给予减低剂量TA方案化疗。结果:观察组临床总有效率高于对照组(P<0.05);与对照组相比,观察组血小板、白细胞和血红蛋白等不良反应显著下降(P<0.05)。结论:减低剂量TA化疗方案对于高龄急性髓系白血病患者具有较好的临床疗效。
Objective:To evaluate the efficacy of reduced dose TA regimen in the treatment of elderly patients with acute myeloid leukemia.Methods:42 elderly patients with acute myeloid leukemia were randomly divided into the control group and the observation group,with 21 cases in each group.The control group were given standard dose of TA chemotherapy,and the observation group were given the reduced dose of TA chemotherapy.Results:The clinical total efficiency of the observation group was higher than that of the control group(P<0.05);compared with the control group,the observation group of patients with thrombocytopenia,white blood cells and hemoglobin and other adverse reactions decreased significantly(P<0.05).Conclusion:Reduced dose of TA chemotherapy regimen has good clinical efficacy in elderly patients with acute myeloid leukemia.
出处
《中国社区医师》
2018年第1期67-67,69,共2页
Chinese Community Doctors
